Combining the Anti-Viral and Anti-Tumor CD8+T Cell Response Facilitates Immune Checkpoint Blockade Therapy and Oncolytic Virotherapy

被引：0

作者：

Sangsuwannukul, Thanich ^{[1
]}

Kendall, Benjamin ^{[1
]}

Webb, Mason J. ^{[1
]}

Vloten, Jacob V. ^{[1
]}

Evgin, Laura ^{[1
]}

Tonne, Jason M. ^{[1
]}

Thompson, Jill ^{[1
]}

Metko, Muriel ^{[1
]}

Moore, Madelyn ^{[1
]}

Yerovi, Maria P. Chiriboga ^{[1
]}

McNiven, Mark ^{[1
]}

Singh, Monga Satdarshan Pal ^{[1
]}

Borad, Mitesh ^{[2
]}

Lewis, Roberts R. ^{[1
]}

Vile, Richard G. ^{[1
]}

机构：

[1] Mayo Clin, Rochester, MN USA

[2] Mayo Clin, Ctr Canc, Scottsdale, AZ USA

来源：

MOLECULAR THERAPY | 2024年 / 32卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

230

引用

页码：123 / 124

页数：2

共 50 条

[41] Single cell analysis reveals that CD8+T cell clone size determines response to immune checkpoint blockade
Watson, R.
Tong, O.
Nassiri, I.
Cooper, R. A.
Taylor, C.
Aires, A. Verge de los
Middleton, M.
Fairfax, B. P.
ANNALS OF ONCOLOGY, 2020, 31 : S1098 - S1098
[42] Anti-Tigit induces T cell mediated anti-tumor immune response and combines with immune checkpoint inhibitors to enhance strong and long term anti-tumor immunity
Srivastava, Minu K.
Yun, Rui
Mayes, Erin
Yu, Janice
Jie, Hyun-Bae
Axelrod, Fumiko
Xie, Ming-Hong
Monteon, Jorge
Lam, Andrew
Ji, May
Liu, Yuwang
Lewicki, John
Hoey, Tim
Gurney, Austin
Park, Angie Inkyung
CANCER RESEARCH, 2017, 77
[43] YTHDF2 promotes tumor immune evasion by inhibiting CD8+T cell-mediated anti-tumor immunity
Ma, Shoubao
Xiao, Sai
Caligiuri, Michael
Yu, Jianhua
JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
[44] IFN1 Blockade Enhances Non-Activated CAR T Cell Anti-Tumor Function Via Inhibiting the Innate Anti-Viral Response
Durgin, Joseph
Kazmi, Shadab
Kelly, Andre
O'Connor, Roddy S.
Ghassemi, Saba
BLOOD, 2024, 144 : 3431 - 3431
[45] CD8+T cell acquisition of the LPS receptor within the hepatic stroma shapes anti-viral/anti-tumour potential
Pallett, Laura J.
Diniz, Mariana
Swadling, Leo
Skelton, Jessica
Maini, Alexander
Davies, Jessica
Kucykowicz, Stephanie
Schmidt, Nathalie
Amin, Oliver E.
Gill, Upkar
Burton, Alice
Sanchez, Jenifer
Fusai, Giuseppe
Lens, Sabela
Perez-del-Pulgar, Sofia
Kennedy, Patrick
Davidson, Brian R.
Haniffa, Muzlifah
Gilroy, Derek
Dorner, Marcus
Schurich, Anna
Maini, Mala
JOURNAL OF HEPATOLOGY, 2022, 77 : S55 - S56
[46] Spectrum of CD1d-restrieted T cells: Control of anti-viral and anti-tumor responses
Exley, Mark A.
van der Vliet, Hans J.
Yue, Simon C.
Wang, Ruojie
Koon, Henry
Avigan, David
Mier, James
Atkins, Michael B.
Balk, Steven P.
JOURNAL OF IMMUNOLOGY, 2006, 176 : S71 - S71
[47] Oncolytic virotherapy stimulates anti-tumor immune response and demonstrates activity in advanced sarcoma: Report of two cases
Qiu, Yeting
Qin, Aijun
Zhao, Ronghua
Ding, Jun
Jia, William Wei-Guo
Singh, Manu
Murad, Yanal
Tan, Qian
Kichenadasse, Ganessan
ONCOLOGY LETTERS, 2024, 27 (06)
[48] Therapeutic vaccine targeting dual immune checkpoints induces potent multifunctional CD8+T cell anti-tumor immunity
Zheng, Yanyan
Lu, Zheng
Zhu, Fei
Zhao, Guangya
Shao, Yingxiang
Lu, Bowen
Ding, Jiage
Wang, Gang
Fang, Lin
Zheng, Junnian
Chai, Dafei
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 142
[49] Manipulation of T cell activation in the anti-tumor immune response
Hurwitz, AA
Leach, DR
van Elsas, A
Townsend, SE
Allison, JP
BIOLOGY OF TUMORS, 1998, : 213 - 222
[50] NKTR-214 enhances anti-tumor T cell immune responses induced by checkpoint blockade or vaccination
Sharma, Meenu
Fa'ak, Faisal
Janssen, Louise
Khong, Hiep
Xiao, Zhilan
Hailemichael, Yared
Singh, Manisha
Vianden, Christina
Diab, Adi
Zalevsky, Jonathan
Hoch, Ute
Overwijk, Willem
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5

← 1 2 3 4 5 →